Concentrations of hepatocyte growth factor in cerebrospinal fluid under normal and different pathological conditions

被引:23
作者
Kern, MA
Bamborschke, S
Nekic, M
Schubert, D
Rydin, C
Lindholm, D
Schirmacher, P
机构
[1] Univ Cologne, Inst Pathol, D-50931 Cologne, Germany
[2] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany
[3] Univ Uppsala, Dept Neurosci, S-75123 Uppsala, Sweden
关键词
blood-brain barrier; central nervous system; enzyme-linked immunosorbent assay; infection; neurotrophic factor;
D O I
10.1006/cyto.2001.0875
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocyte growth factor (HGF) and its specific receptor, MET, are expressed in the developing and adult mammalian brain. Recent studies have shown a neurotrophic activity of HGF in the nervous system. The present study focused on HGF concentrations in the cerebrospinal fluid (CSF) and serum in normal persons and in different central nervous system (CNS) diseases considering blood-CSF barrier (BCB) function. Concentrations of HGF were analyzed using an enzyme-linked immunosorbent assay (ELISA). HGF was present in normal human CSF (346 +/- 126 pg/ml) representing approximately half of the HGF serum concentrations. The CSF HGF levels were not significantly changed in chronic CNS disease and in aseptic meningitis (419 +/- pg/ml), but significantly increased in patients with bacterial meningitis (6101 +/- 5200 pg/ml). The HGF levels in CSF mere not influenced by increased serum concentrations in patients with normal or mildly affected BCB function. The results show that HGF is present in normal CSF and does not appear to cross the CSF barrier significantly unless it is severely disrupted. So far, strong increases of HGF concentration in CSF are only present in acute bacterial meningitis. (C) 2001 Academic Press.
引用
收藏
页码:170 / 176
页数:7
相关论文
共 31 条
[1]   Expression of HGF and cMet in the developing and adult brain [J].
Achim, CL ;
Katyal, S ;
Wiley, CA ;
Shiratori, M ;
Wang, G ;
Oshika, E ;
Petersen, BE ;
Li, JM ;
Michalopoulos, GK .
DEVELOPMENTAL BRAIN RESEARCH, 1997, 102 (02) :299-303
[2]   Passage of cytokines across the blood-brain barrier [J].
Banks, WA ;
Kastin, AJ ;
Broadwell, RD .
NEUROIMMUNOMODULATION, 1995, 2 (04) :241-248
[3]   PEPTIDES AND THE BLOOD-BRAIN-BARRIER - LIPOPHILICITY AS A PREDICTOR OF PERMEABILITY [J].
BANKS, WA ;
KASTIN, AJ .
BRAIN RESEARCH BULLETIN, 1985, 15 (03) :287-292
[4]  
Beilmann M, 1997, BLOOD, V90, P4450
[5]   HEPATOCYTE GROWTH-FACTOR SCATTER FACTOR INDUCES A VARIETY OF TISSUE-SPECIFIC MORPHOGENIC PROGRAMS IN EPITHELIAL-CELLS [J].
BRINKMANN, V ;
FOROUTAN, H ;
SACHS, M ;
WEIDNER, KM ;
BIRCHMEIER, W .
JOURNAL OF CELL BIOLOGY, 1995, 131 (06) :1573-1586
[6]   HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH [J].
BUSSOLINO, F ;
DIRENZO, MF ;
ZICHE, M ;
BOCCHIETTO, E ;
OLIVERO, M ;
NALDINI, L ;
GAUDINO, G ;
TAMAGNONE, L ;
COFFER, A ;
COMOGLIO, PM .
JOURNAL OF CELL BIOLOGY, 1992, 119 (03) :629-641
[7]   Bioavailability and transport of peptides and peptide drugs into the brain [J].
Egleton, RD ;
Davis, TP .
PEPTIDES, 1997, 18 (09) :1431-1439
[8]   EVALUATION OF BLOOD-CSF BARRIER BY PROTEIN GRADIENTS AND HUMORAL IMMUNE-RESPONSE WITHIN CENTRAL NERVOUS-SYSTEM [J].
FELGENHAUER, K ;
SCHLIEP, G ;
RAPIC, N .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1976, 30 (01) :113-128
[9]   PURIFICATION AND PARTIAL CHARACTERIZATION OF HEPATOCYTE GROWTH-FACTOR FROM PLASMA OF A PATIENT WITH FULMINANT HEPATIC-FAILURE [J].
GOHDA, E ;
TSUBOUCHI, H ;
NAKAYAMA, H ;
HIRONO, S ;
SAKIYAMA, O ;
TAKAHASHI, K ;
MIYAZAKI, H ;
HASHIMOTO, S ;
DAIKUHARA, Y .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 81 (02) :414-419
[10]   EXPRESSION AND FUNCTIONAL INTERACTION OF HEPATOCYTE GROWTH FACTOR-SCATTER FACTOR AND ITS RECEPTOR C-MET IN MAMMALIAN BRAIN [J].
JUNG, W ;
CASTREN, E ;
ODENTHAL, M ;
VANDEWOUDE, GF ;
ISHII, T ;
DIENES, HP ;
LINDHOLM, D ;
SCHIRMACHER, P .
JOURNAL OF CELL BIOLOGY, 1994, 126 (02) :485-494